Beleaguered Novo offers relief to investors, thanks to Wegovy pill
AI Summary
Novo Nordisk raised its guidance after strong uptake of its newly launched Wegovy weight-loss pill, lifting investor sentiment and the company’s stock. The update provides relief to investors amid a difficult period for the Danish drugmaker.
Novo Nordisk stock jumped higher on Wednesday as the Danish drugmaker lifted its guidance on strong uptake of its weight-loss drug pill that has been launched this year.